FIELD: medicine.
SUBSTANCE: method involves intravenously introducing autoblood to patients having initial vision acuity of not less than 0.2. Blood is taken after keeping patient 45min long in darkness with the eyes open. The blood is taken under normal illumination conditions with light-impermeable bandage on patient eyes.
EFFECT: enhanced effectiveness of treatment.
2 cl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING BLOOD WITH INCREASED CONTENT OF NUCLEOSIDES AND NUCLEOTIDES | 2004 |
|
RU2290938C2 |
METHOD FOR IMPROVING ACUITY IN PATIENTS WITH VASCULAR AND DYSTROPHIC RETINAL DISEASES | 2003 |
|
RU2258490C1 |
METHOD FOR CYTOFLAVIN ELECTRIC ACCUMULATION IN TREATING VASCULAR AND DYSTROPHIC RETINAL AND VISUAL NERVE DISEASES | 2011 |
|
RU2462280C1 |
METHOD OF PREVENTION AND TREATMENT OF RETINOPATHY IN DYSMATURE INFANTS | 2008 |
|
RU2387416C1 |
METHOD FOR THERAPEUTIC TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 2003 |
|
RU2244528C1 |
METHOD OF VISUAL ACUITY PREDICTION | 2007 |
|
RU2353298C1 |
METHOD OF TREATING ENDOTHELIAL-EPITHELIAL DYSTROPHY OF CORNEA | 2020 |
|
RU2730975C1 |
METHOD OF IMPROVEMENT OF VISUAL FUNCTIONS AT PRIMARY OPEN ANGLE GLAUCOMA WITH NORMALISED INTRAOCULAR TENSION | 2007 |
|
RU2351299C1 |
METHOD FOR TREATING HEMOPHTHALMIA | 1997 |
|
RU2148972C1 |
METHOD OF TREATING DISEASES OF OPTIC NERVE AND RETINA | 2008 |
|
RU2373904C1 |
Authors
Dates
2007-01-20—Published
2004-12-15—Filed